ApprovalTrail

Approval · Notice of Compliance 11330 · 2010

FENTANYL: Notice of Compliance 11330

Issued April 29, 2010

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
11330
Date
April 29, 2010
Company
Public Benefits PharmaToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Reason
New manufacturer and product name
Therapeutic class
Opioid analgesic
Canadian reference product
DURAGESIC (Janssen-Ortho Inc.)

Products in this notice

BrandDINStatus today
FENTANYL02349876—
FENTANYL02349884—
FENTANYL02349892—
FENTANYL02349906—
FENTANYL02349914—

Medicinal ingredients